Momenta Pharmaceuticals
Latest round
- Series C
Last raised
- Feb 2004
Total raised
- $40M
Investors
- 4
About Momenta Pharmaceuticals
, operates as a biotechnology company that focuses on the characterization and engineering of Neurology and Hematology therapeutics to treat patients with rare immune-mediated disease.
Who invested in Momenta Pharmaceuticals
4 investors across 3 rounds
See all investors in Momenta Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Momenta Pharmaceuticals
Who invested in Momenta Pharmaceuticals?
Momenta Pharmaceuticals has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Momenta Pharmaceuticals raised?
Momenta Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Momenta Pharmaceuticals last raise money?
Momenta Pharmaceuticals's most recent round on record is a Series C, in Feb 2004.
What does Momenta Pharmaceuticals do?
, operates as a biotechnology company that focuses on the characterization and engineering of Neurology and Hematology therapeutics to treat patients with rare immune-mediated disease.
Where is Momenta Pharmaceuticals headquartered?
Momenta Pharmaceuticals is headquartered in Cambridge, US.
Which VCs invest in companies like Momenta Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Momenta Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Momenta Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.